2 months Q3 EPS Estimates for Legend Biotech Boosted by HC Wainwright MarketBeat
Legend Biotech Co. (NASDAQ:LEGN – Free Report) – Equities researchers at HC Wainwright lifted their Q3 2024 EPS estimates for Legend Biotech in a note issued to investors on Wednesday, October 16th. HC Wainwright analyst M. Kapoor now forecasts that…
Biotech · Earnings · Nasdaq 100 · Science
X